FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to oncology and can be used in treating a subject mammal with a new growth. A method under the invention involves the introduction in a subject of avian penumoencephailitis virus and a camptothecin compound. Also, the method can include in addition the introduction to the subject of a monoclonal epidermal growth factor receptor antibody. Versions of application under the invention concern a combination of avian penumoencephailitis virus and said camptothecin compound for preparing a drug.
EFFECT: use of the inventions allows higher clinical effectiveness of new growths due to synergistic antineoplastic action of camptothecins and avian penumoencephailitis virus.
17 cl, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CANCER TREATMENT WITH APPLICATION OF VIRUSES FLUOROPYRIMIDINES AND CAMPTOTHECINS | 2006 |
|
RU2435586C2 |
| METHOD FOR INTRODUCING THERAPEUTIC VIRUSES | 2003 |
|
RU2314830C2 |
| COMBINED ANTICANCER THERAPY | 2011 |
|
RU2607596C2 |
| PHARMACEUTICAL COMBINATIONS | 2017 |
|
RU2759669C2 |
| METHOD FOR ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY STRENGTHENING | 2011 |
|
RU2627660C2 |
| METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPY COMPRISING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2663450C2 |
| METHODS OF TREATING PANCREAS CANCER USING COMBINATION THERAPY INCLUDING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2808427C2 |
| METHOD OF TREATING CANCER ASSOCIATED WITH A RAS MUTATION | 2016 |
|
RU2736045C2 |
| COMBINATION THERAPY USING LIPOSOMAL IRINOTECAN AND PARP INHIBITOR FOR THE TREATMENT OF CANCER | 2016 |
|
RU2760185C2 |
| THERAPEUTIC COMBINATIONS CONTAINING INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE | 2005 |
|
RU2361592C2 |
